ArticleTherapeutic advances in medical oncology2021

Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US.

Ran Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.